290 related articles for article (PubMed ID: 30759352)
1. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.
Wiese AD; Griffin MR; Grijalva CG
Expert Rev Vaccines; 2019 Apr; 18(4):327-341. PubMed ID: 30759352
[TBL] [Abstract][Full Text] [Related]
2. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
Tsaban G; Ben-Shimol S
Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
[TBL] [Abstract][Full Text] [Related]
3. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
van Werkhoven CH
Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.
Madhi SA; Nunes MC
Hum Vaccin Immunother; 2016; 12(2):314-25. PubMed ID: 26317537
[TBL] [Abstract][Full Text] [Related]
5. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
[TBL] [Abstract][Full Text] [Related]
6. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies.
Mackenzie GA; Hill PC; Sahito SM; Jeffries DJ; Hossain I; Bottomley C; Uchendu U; Ameh D; Ndiaye M; Osuorah CD; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Ahameefula E; Muhammad BS; Fombah AE; Saha D; Mackenzie R; Plumb I; Akano A; Ebruke B; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UNA; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Sowe D; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
Lancet Infect Dis; 2017 Sep; 17(9):965-973. PubMed ID: 28601421
[TBL] [Abstract][Full Text] [Related]
7. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
[TBL] [Abstract][Full Text] [Related]
9. Invasive Pneumococcal Disease burden and PCV coverage in children under five in Southeast Asia: implications for India.
Kolhapure S; Yewale V; Agrawal A; Krishnappa P; Soumahoro L
J Infect Dev Ctries; 2021 Jun; 15(6):749-760. PubMed ID: 34242182
[TBL] [Abstract][Full Text] [Related]
10. Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
Maeda H; Gopal Dhoubhadel B; Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
Vaccine; 2022 Sep; 40(37):5504-5512. PubMed ID: 35963821
[TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
[TBL] [Abstract][Full Text] [Related]
12. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
[TBL] [Abstract][Full Text] [Related]
13. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
[TBL] [Abstract][Full Text] [Related]
14. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.
Wasserman M; Chapman R; Lapidot R; Sutton K; Dillon-Murphy D; Patel S; Chilson E; Snow V; Farkouh R; Pelton S
Emerg Infect Dis; 2021; 27(6):1627-1636. PubMed ID: 34013855
[TBL] [Abstract][Full Text] [Related]
15. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?
Weil-Olivier C; Gaillat J
Vaccine; 2014 Apr; 32(18):2022-6. PubMed ID: 24565755
[TBL] [Abstract][Full Text] [Related]
16. Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain.
Rivero-Calle I; Pardo Seco J; Raguindin PF; Alvez F; Gómez-Rial J; Salas A; Martinón Sanchez J; Martinón-Torres F
Hum Vaccin Immunother; 2020 Jun; 16(6):1446-1453. PubMed ID: 31851569
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
[TBL] [Abstract][Full Text] [Related]
18. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance.
; Mackenzie GA; Hill PC; Jeffries DJ; Ndiaye M; Sahito SM; Hossain I; Uchendu U; Ameh D; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Ahameefula E; Fombah AE; Adeshola B; Lobga BG; Saha D; Mackenzie R; Odutola A; Plumb ID; Akano A; Ebruke BE; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UN; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Fofana S; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
Lancet Infect Dis; 2021 Sep; 21(9):1293-1302. PubMed ID: 34280357
[TBL] [Abstract][Full Text] [Related]
19. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.
Hsiao A; Hansen J; Timbol J; Lewis N; Isturiz R; Alexander-Parrish R; McLaughlin JM; Gessner BD; Klein NP
JAMA Netw Open; 2022 Mar; 5(3):e221111. PubMed ID: 35302634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
